Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 04-2026 | 01-2026 | 10-2025 | 07-2025 | 04-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,416 | 9,258 | 3,923 | 3,495 | 4,473 |
| Marketable Securities | 2,178 | 1,089 | 1,662 | 1 | 178 |
| Receivables | 552 | 438 | 322 | 211 | 181 |
| TOTAL | $14,323 | $11,021 | $5,948 | $3,822 | $5,023 |
| Non-Current Assets | |||||
| Intangibles | 92 | 95 | 97 | 100 | 103 |
| Other Non-Current Assets | 109 | 28 | 38 | 47 | 55 |
| TOTAL | $201 | $123 | $135 | $148 | $158 |
| Total Assets | $14,524 | $11,143 | $6,083 | $3,970 | $5,181 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 1,760 | N/A | N/A |
| Accounts payable and accrued liabilities | 811 | 1,140 | 742 | 697 | 525 |
| Other current liabilities | 2,136 | 1,757 | 2,369 | 2,179 | 2,318 |
| TOTAL | $2,988 | $2,905 | $4,891 | $2,904 | $2,879 |
| Non-Current Liabilities | |||||
| TOTAL | $44 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,033 | $2,905 | $4,891 | $2,904 | $2,879 |
| Shareholders' Equity | |||||
| Common Shares | 42,663 | 35,949 | 26,403 | 25,570 | 25,338 |
| Retained earnings | -33,782 | -31,734 | -27,880 | -27,192 | -25,878 |
| Other shareholders' equity | 2,610 | 4,024 | 2,670 | 2,688 | 2,841 |
| TOTAL | $11,491 | $8,238 | $1,193 | $1,066 | $2,302 |
| Total Liabilities And Equity | $14,524 | $11,143 | $6,083 | $3,970 | $5,181 |